Holger Schmidt

Holger Schmidt

Berlin

Holger Schmidt is an advisor to executives in the health industry for Strategy&, PwC’s strategy consulting group. He is a Managing Director Strategy& Germany, based in Berlin. He is a member of the global Health practice, focuses on R&D and commercial strategy, and works with pharmaceutical, biotech, and medtech companies and providers. He also has cross-industry experience in telecommunications and consumer goods. His experience spans the E.U., U.S., and emerging markets, including Brazil, Russia, Korea, and Australia.

His areas of expertise include:

  • Product and portfolio strategies along the whole product lifecycle (e.g. R&D strategies, launch strategies, LCM strategies)
  • Business strategies (e.g. due diligences, growth strategies, corporate strategies)
  • Organisational strategies (e.g. business process design, organizational design, change)

Holger Schmidt’s client work has included:

Product and portfolio strategies

  • Brand strategy and launch program for a respiratory product
  • Launch planning for a cardiovascular product
  • Mature markets pricing strategy for a consumer brand
  • LCM strategy for a mature cardiovascular product
  • Portfolio strategy oncology

Business strategies

  • Corporate strategy for a biotech startup
  • Commercial due diligence of a major hospital chain
  • Go to market model development for a medtech startup
  • Business plan evaluation of a nuclear research facility
  • Business blueprint for a patient service program
  • Business concept for a healthcare focused real estate development at a major airport
  • Enabling growth for a pharmaceutical contract manufacturer
  • Healthcare strategy for a major testing, inspection, certification company

Organizational strategies

  • Set up of a global market access organisation for a pharma company
  • Development of a portfolio management process for major pharma company
  • Reorganisation of a pharma country organisation after sales decline
  • Set up of a global key account management for a pharma company
  • Optimisation of the go-to-market strategy and reorganisation of a country organisation of a major pharmaceutical company

A licensed physician, Holger Schmidt studied medicine at RWTH Aachen and Humboldt University Berlin and participated in exchange programs with Rijksuniversiteit Masstricht, Universidad de Barcelona and Tribhuvan University Kathmandu.

Authored articles